Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Alkermes plc (ALKS) vs Hims & Hers Health, Inc. (HIMS)

Alkermes plc and Hims & Hers Health, Inc. are both Drug Manufacturers Specialty & Generic companies. Alkermes plc and Hims & Hers Health, Inc. are of similar size ($6.9B and $6.8B). Hims & Hers Health, Inc. has negative trailing earnings, so its P/E is not meaningful; Alkermes plc trades at 101×. Hims & Hers Health, Inc. grew revenue faster over the last twelve months: 28.0% against 10.8%. Alkermes plc has the higher net margin (3.97% vs −5.51%) and the higher return on invested capital (2.76% vs −11.4%). Across the 19 metrics below, Alkermes plc leads on 14 and Hims & Hers Health, Inc. on 5.

Valuation

Metric ALKS HIMS Drug Manufacturers Specialty & Generic median
P/E 101.36 n/m 20.14
P/S 4.09 2.65 2.25
P/B 3.77 21.07 1.90
Price to free cash flow 30.64 82.23 16.54
EV/EBITDA 34.45 n/m 12.29
EV/Sales 4.60 2.85 2.56
Earnings yield 0.99% (2.07%) (2.99%)
Free cash flow yield 3.26% 1.22% 0.00%

Profitability

Metric ALKS HIMS Drug Manufacturers Specialty & Generic median
Gross margin 84.56% 68.43% 53.94%
Operating margin 7.03% (5.99%) 0.00%
Net margin 3.97% (5.51%) 0.00%
Free cash flow margin 13.35% 3.22% 0.00%
Return on equity 3.85% (32.03%) (0.40%)
Return on assets 1.99% (5.16%) (3.32%)
Return on invested capital 2.76% (11.38%) 0.00%

Growth

Metric ALKS HIMS Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 10.79% 28.04% 10.01%
EPS growth (last fiscal year) (34.10%) (3.77%) —
Revenue growth, 5-year CAGR 7.28% 53.90% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALKS HIMS Drug Manufacturers Specialty & Generic median
Debt to equity 0.83 4.21 0.05
Current ratio 2.30 0.93 2.31
Net debt to EBITDA (4.69) 2.43 0.85

Dividend

Metric ALKS HIMS Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric ALKS HIMS Drug Manufacturers Specialty & Generic median
Market cap 6.78b 6.87b 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack